d="p0010">Invasive lobular carcinoma (ILC) is a clinically and molecularly distinct disease
dd><dt class="label">•dt><dd>d="p0015">ILCs show CDH1 and PTEN loss, AKT activation, and mutations in TBX3 and FOXA1
dd><dt class="label">•dt><dd>d="p0020">Proliferation and immune-related gene expression signatures define 3 ILC subtypes
dd><dt class="label">•dt><dd>d="p0025">Genetic features classify mixed tumors into lobular-like and ductal-like subgroups
dd>dl>